- AU$206.36m
- AU$169.56m
- AU$387.35m
Brief: Mayne Pharma Announces Outcome Of Litigation And Update On Scheme
Mayne Pharma at 8-month high as court blocks Cosette's plan to terminate takeover offer
Cosette's attempt to drop $438 million Mayne Pharma deal denied by court (updated)
Cosette's attempt to drop $438 million Mayne Pharma deal denied by court
Mayne Pharma slips 15% on reports of FIRB intervention in Cosette deal
Brief: Mayne Pharma Addresses Recent Media Articles Regarding FIRB
Australia's Mayne Pharma rises as annual loss narrows
Brief: Mayne Pharma Receives Additional Notice Of Intention To Terminate From Cosette
Brief: Mayne Pharma Says 89.64% Shareholders At Scheme Meeting Voted In Favour Of Scheme Resolution
Brief: Mayne Pharma Reports Commencement of Court Proceedings Against Cosette
Brief: Mayne Pharma Receives Further Purported Notice To Terminate Scheme Implementation Deed From Cosette
Brief: Mayne Pharma Says Directors Unanimously Recommend Shareholders Vote In Favour Of Scheme
Australia's Mayne Pharma set to snap 4-session skid on pushing ahead with Cosette scheme
Brief: Mayne Pharma Receives Purported Notice To Terminate SID
Australia's Mayne Pharma slides on US co's notice to scrap $432 mln deal
Brief: Mayne Pharma Says 10 Business Day Consultation Period Asserted By Cosette Now Expired
Brief: Mayne Pharma Posts Update On US Legal Proceeding With Therapeuticsmd Inc
Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal (updated)
Australia's Mayne Pharma plunges on potential deal collapse with Cosette